CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-22 | Litchfield Caroline EVP & CFO | Grant or award | +19,208 | $119.43 | $2.3M | 50,908.19 |
| 2024-01-22 | Klobuchar Michael A EVP - Chief Strategy Officer | Grant or award | +3,896 | $119.43 | $465K | 23,098.14 |
| 2023-12-29 | WENDELL PETER C Director | Grant or award · Phantom Stock | +275.18 | $109.02 | $30K | 123,715.51 |
| 2023-12-29 | Seidman Christine E Director | Grant or award · Phantom Stock | +74.53 | $109.02 | $8K | 12,775.22 |
| 2023-12-29 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +412.77 | $109.02 | $45K | 92,419.17 |
| 2023-12-29 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +275.18 | $109.02 | $30K | 20,688.4 |
| 2023-11-09 | Oosthuizen Johannes Jacobus President, U.S. Market | Sale | −2,081 | $102.38 | $213K | 18,190.66 |
| 2023-11-08 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Sale | −43,823 | $105.03 | $4.6M | 111,763.59 |
| 2023-10-31 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Grant or award · Restricted Stock Unit | +11,685 | 11,685 | ||
| 2023-10-30 | Oosthuizen Johannes Jacobus President, U.S. Market | Option exercise | +915 | $102.82 | $94K | 20,722.66 |
| 2023-10-30 | Oosthuizen Johannes Jacobus President, U.S. Market | Shares withheld for taxes | −451 | $102.82 | $46K | 20,271.66 |
| 2023-10-30 | Oosthuizen Johannes Jacobus President, U.S. Market | Option exercise · Restricted Stock Unit | −915 | 0 | ||
| 2023-09-29 | WENDELL PETER C Director | Grant or award · Phantom Stock | +291.4 | $102.95 | $30K | 122,580.96 |
| 2023-09-29 | Seidman Christine E Director | Grant or award · Phantom Stock | +78.92 | $102.95 | $8K | 12,612.61 |
| 2023-09-29 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +437.11 | $102.95 | $45K | 91,370.99 |
| 2023-09-29 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +291.4 | $102.95 | $30K | 20,272.8 |
| 2023-08-14 | MIZELL STEVEN EVP, Chief HR Officer | Sale | −4,250 | $109.01 | $463K | 22,935.15 |
| 2023-08-03 | Guindo Chirfi Chief Marketing Officer | Option exercise | +36,901 | $105.70 | $3.9M | 38,341.68 |
| 2023-08-03 | Guindo Chirfi Chief Marketing Officer | Shares withheld for taxes | −17,989 | $105.70 | $1.9M | 20,352.68 |
| 2023-08-03 | Guindo Chirfi Chief Marketing Officer | Option exercise · Restricted Stock Unit | −36,901 | 73,804 |
Page 20 of 29 · 572 trades